Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of mononuclear cells in rheumatoid arthritis.
Dimitrijevic
M
M
Department of Microbiology and Immunology, University School of Pharmacy, Belgrade, Yugoslavia.
Bartlett
R R
RR
D015703:Antigens, CD / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D002449:Cell Aggregation / Q000187:drug effects; D002478:Cells, Cultured; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007555:Isoxazoles / Q000494:pharmacology*; D000077339:Leflunomide; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D013582:Synovial Fluid / Q000276:immunology; D013755:Tetradecanoylphorbol Acetate
D015703:Antigens, CD; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide; D013755:Tetradecanoylphorbol Acetate